Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  Series C |

---

|  |  |  |
| --- | --- | --- |
|  | C/2023/979 | 27.11.2023 |

Judgment of the General Court of 11 October 2023 — Pascoe pharmazeutische Präparate v EUIPO — Novartis Pharma (PASCELMO)

(Case T-435/22) [(1)](#ntr1-C_202300979EN.000101-E0001)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark PASCELMO - Earlier EU word mark PASCOE - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001))

(C/2023/979)

Language of the case: English

Parties

Applicant: Pascoe pharmazeutische Präparate GmbH (Gießen, Germany) (represented by: M. Kinkeldey, S. Brandstätter, S. Clotten and C. Schmitt, lawyers)

Defendant: European Union Intellectual Property Office (represented by: M. Eberl, J. Ivanauskas and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Novartis Pharma AG (Basle, Switzerland)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 4 May 2022 (Case R 1890/2021-2).

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Pascoe pharmazeutische Präparate GmbH to pay the costs. |

---

---

ELI: http://data.europa.eu/eli/C/2023/979/oj

ISSN 1977-091X (electronic edition)

---

[Top](#document1)